INTRODUCTION
Non-Hodgkin's lymphoma (NHL) is a rare disease in the very young children 1, 2 . Small noncleaved cell lymphoma (SNCCL) and Burkitt's and Burkitt-like lymphomas comprise 40% -50% of childhood lymphomas 3 . The incidence of SNCCL is age-dependent, being much higher in the first 2 decades of life; SNCCL has not been reported in children under 2 years of age. These lymphomas are B cell in origin and have the immunophenotypic characteristics of a subset of germinal center cells. Rare cases of Burkitt and Burkitt-like lymphoma have been reported in infants 2, 3 . We herein describe a case of a Burkitt-like SNCCL in a very young child.
CASE REPORT
A 13-month-old female infant developed diarrhea and failure to thrive. Physical examination revealed a mass in lower abdominal quadrant and ascites. Computed tomography showed extensive intra-abdominal disease and right pleural effusion. Laboratory findings showed: red blood count, 3.67 x 10 12 /L; hemoglobin concentration, 9.5g/dL; haematocrit, 29%; platelet count, 514 x 10 6 /L; white blood cell count, 10.9 x 10 6 /L with 31% lymphocytes and 76% neutrophils.
High blood levels of lactic dehydrogenase (LDH), 2171 IU, and uric acid (9.2 mg/dL) were consistent with mild tumor lysis syndrome. An exploratory laparatomy was performed and revealed diffuse abdominal involvement including omentum and ovaries, which were biopsied. The histopathological analysis showed neoplastic cells similar in appearance to those of Burkitt's lymphoma, but there was increased pleomorphism over that accepted for Burkitt's lymphoma (greater variation in cell size and shape). The cells tended to have a more finely dispersed chromatin pattern and sometimes had a single prominent eosinophilic nucleolus. Burkitt-like SNCCL was diagnosed. Cytogenetic analysis was not performed in this case.
Immunohistochemistry showed strong positivity for CD20 (L26 DAKO). Pleural effusion phenotypic analysis by flow cytometry was positive for HLA Dr, CD19, CD20, IgM, and CD45 and negative for CD34, CD3, CD4, and CD8. The cerebrospinal fluid and bone marrow were negative for the disease. The St. Jude staging system was applied, and the patient was classified as having stage III disease.
B-cell clonality was detected by PCR using oligonucleotide primers to amplify rearranged CDRII and CDRIII regions (semi-nested FR2-JH and FR3-JH PCRs) of immunoglobulin heavy chain (IgH) as described elsewhere 4, 5 ( Fig. 1 ). The HIV test was negative in the child and her parents. In situ hybridization for Epstein-Barr encoded RNAs was negative. No evidence of immunodeficiency was found in this child. The patient was treated with a BFM (Berlin-Frankfurt-Münsten)-based protocol 6 and developed markedly elevated serum uric acid levels, severe electrolyte imbalance, and renal failure, but recovered with appropriate treatment. She remains alive, in complete remission for 30 months.
DISCUSSION
Burkitt's lymphoma (BL) is a Bcell neoplasm classified in the National Cancer Institute Working Formulation as small, noncleaved cell lymphoma 7 . In Equatorial Africa, BL is the most common childhood malignancy, accounting for approximately 80% of childhood cancers and is called "endemic" (eBL). In contrast, outside Equatorial Africa, BL occurs in a sporadic form (sBL). Epstein-Barr (EBV) viral DNA is found in virtually all cases of eBL, but in only 15% -30% of sBL from the United States 8 . In South America, high association of EBV with BL was reported in the Northeast area of Brazil and these EBV associated BL were observed in young children 9 . Both eBL and sBL are characterized by specific chromosomal translocations that juxtapose areas within or near the c-myc protooncogene locus on chromosome 8 to an Ig gene locus on chromosome 2, 14, or 22. The resulting deregulation of the c-myc gene has been implicated in the pathogenesis of the disease 10 . Previous studies have shown that the cases classified as Burkitt-like lacked c-myc rearrangement and had different molecular pathogenesis than BL 11, 12 . Unfortunately, in this case, the molecular distinction between the two categories was not performed, and the diagnosis was made according to the morphologic criteria defined by the REAL classification 13 . This patient presented a B-cell lymphoma at an unusually young age at diagnosis. The histological examination revealed a Burkitt-like SNCCL. Non-Hodgkin's lymphoma (NHL) including Burkitt and Burkitt-like, are rarely described in infants. In 338 consecutive newly diagnosed children with NHL, Murphy et al., found that 4.8% of them were younger than 3 years of age 1 . Evans et al., reported 6 children who developed NHL before the age of 3 years associated with mother-to-child HIV transmission 14 . In another report of NHL in children with vertical HIV infection, 21.7% were under 2 years old 15 . We have identified 1 infant patient with a Burkitt-like SNCCL whose HIV test was negative in the child and her mother, and the EBV genome was not detected by in situ hybridization, despite the previously described relationship between young age and HIV infection and these lymphomas 10, 11 . Prior to the last two decades, childhood Burkitt's NHL was a fatal disease in most of the cases. In 1976, Wollner et al. reported the excellent results on the treatment of childhood NHL using a novel multiagent chemotherapeutic regimen, LSA 2 L 2 16 . Several reports in the past 10 years have shown that event-free survival has significantly improved 6, [17] [18] [19] . Patients with limited disease currently have an excellent prognosis (90% -100%) 6, 17 . The probability of cure is obviously influenced by many factors, among which the most important are the total body burden of tumor and intensity of chemotherapy 6 . The former is reflected mainly by the stage of disease and LDH serum level at diagnosis 20 . In the past, the prognosis for patients with high tumor burdens or with central nervous system involvement was very poor 21 . This situation has changed markedly in recent years, and patients with stage III Burkitt and Burkitt-like SNCCL including those with extensive intra-abdominal disease, have a 60% -80% long-term survival rate 6, 18 . Tumor lysis syndrome is often present at diagnosis or after initiation of treatment. This emergent clinical situation should be anticipated prior to starting treatment. Despite the high tumor burden found, our patient achieved longterm complete remission, probably related to the intensive therapy.
The current report illustrates the importance of considering NHL in the differential diagnosis of neoplasia in very young children, even when HIV is not present. 
RESUMO

